Gadolinium-dependent distinction brokers (GBCAs) are extensively used in magnetic resonance imaging (MRI) to reinforce the visibility of blood vessels, tumors, inflammation, and various interior constructions. Although typically regarded as Secure, concerns about GBCA toxicity have emerged in the last two decades—significantly in sufferers with i